Judith M. Matthews - Chief Financial Officer at Iterum Therapeutics plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
ITRM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Judith M. Matthews since 7/7/2023

Holdings reported by Judith M. Matthews for Iterum Therapeutics plc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 100,000 $81 K $0.81 Mar 31, 2023 Direct Ordinary Shares
Ordinary Shares 8,135 $11.4 K $1.40 Mar 11, 2023 Direct
Restricted Share Units 0 Mar 11, 2023 Direct Ordinary Shares

Transactions reported by Judith M. Matthews for Iterum Therapeutics plc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership